MEDNAX, INC. (NYSE:MD) Files An 8-K Results of Operations and Financial Condition

Item2.02

On April20, 2017, MEDNAX, Inc., a Florida corporation (the
Company), issued a press release announcing its preliminary
results of operations for the three months ended March31, 2017.A
copy of the press release is attached hereto as Exhibit 99.1 and
is hereby incorporated in this Current Report by reference.The
information contained in this Item 2.02, including Exhibit 99.1,
shall not be deemed filed with the Securities and Exchange
Commission nor incorporated by reference in any registration
statement or other document filed by the Company under the
Securities Act of 1933, as amended, except as shall be expressly
set forth by specific reference in such filing.

(d) Exhibits.

99.1Press Release of MEDNAX, Inc. dated April20, 2017.

About MEDNAX, INC. (NYSE:MD)

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.

MEDNAX, INC. (NYSE:MD) Recent Trading Information

MEDNAX, INC. (NYSE:MD) closed its last trading session down -0.46 at 66.69 with 1,274,103 shares trading hands.